{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:02:01Z","timestamp":1776988921850,"version":"3.51.4"},"reference-count":12,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2022,2,4]]},"DOI":"10.18632\/oncotarget.28189","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T13:12:14Z","timestamp":1643980334000},"page":"281-290","source":"Crossref","is-referenced-by-count":5,"title":["GZ17-6.02 and axitinib interact to kill renal carcinoma cells"],"prefix":"10.18632","volume":"13","author":[{"given":"Laurence","family":"Booth","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"West","sequence":"additional","affiliation":[{"name":"Genzada Pharmaceuticals, Sterling, KS 67579, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Moore","sequence":"additional","affiliation":[{"name":"Genzada Pharmaceuticals, Sterling, KS 67579, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Von","family":"Hoff","sequence":"additional","affiliation":[{"name":"Physician-in-Chief, Distinguished Professor, Translational Genomics Research Institute (TGEN), Phoenix, AZ 85004, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dent","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.1002\/jcp.29464","article-title":"GZ17-6.02 initiates DNA damage causing autophagosome-dependent HDAC degradation resulting in enhanced anti-PD1 checkpoint inhibitory antibody efficacy","volume":"23","author":"Dent","year":"2020","journal-title":"J Cell Physiol"},{"key":"2","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3389\/fonc.2020.01331","article-title":"GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling","volume":"1","author":"Dent","year":"2020","journal-title":"Front Oncol"},{"key":"3","doi-asserted-by":"publisher","first-page":"656453","DOI":"10.3389\/fonc.2021.656453","article-title":"GZ17-6.02 Interacts With [MEK1\/2 and B-RAF Inhibitors] to Kill Melanoma Cells","volume":"1","author":"Dent","year":"2021","journal-title":"Front Oncol"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1764905","article-title":"A novel plant-derived compound is synergistic with 5-fluorouracil and has increased apoptotic activity through autophagy in the treatment of actinic keratoses","author":"Dent","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"5","doi-asserted-by":"publisher","first-page":"711043","DOI":"10.3389\/fonc.2021.711043","article-title":"GZ17-6.02 and Pemetrexed Interact to Kill Osimertinib-Resistant NSCLC Cells That Express Mutant ERBB1 Proteins","volume":"1","author":"Dent","year":"2021","journal-title":"Front Oncol"},{"key":"6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.18632\/oncotarget.28177","article-title":"GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells","volume":"1","author":"Dent","year":"2022","journal-title":"Oncotarget"},{"key":"7","unstructured":"Key Statistics About Kidney Cancer. American Cancer Society. https:\/\/www.cancer.org\/cancer\/kidney-cancer\/about\/key-statistics.html."},{"key":"8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ajur.2021.05.013","article-title":"Biomarkers in renal cell carcinoma: Are we there yet?","volume":"8","author":"Vogelzang","year":"2021","journal-title":"Asian J Urol"},{"key":"9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma","volume":"4","author":"Kon","year":"2013","journal-title":"Nat Genet"},{"key":"10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.pathol.2.010506.092049","article-title":"Von Hippel-Lindau disease","volume":"2","author":"Kaelin","year":"2007","journal-title":"Annu Rev Pathol"},{"key":"11","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.febslet.2012.04.032","article-title":"Systemic VHL gene functions and the VHL disease","volume":"58","author":"Hsu","year":"2012","journal-title":"FEBS Lett"},{"key":"12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrurol.2010.47","article-title":"The genetic basis of kidney cancer: a metabolic disease","volume":"7","author":"Schmidt","year":"2010","journal-title":"Nat Rev Urol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T13:12:17Z","timestamp":1643980337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2,4]]}},"alternative-id":["28189"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28189","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,4]]}}}